Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Inventory (2016 - 2023)

Perspective Therapeutics' Inventory history spans 13 years, with the latest figure at $1.0 million for Q3 2023.

  • On a quarterly basis, Inventory fell 34.77% to $1.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $1.0 million, a 34.77% decrease, with the full-year FY2022 number at $1.4 million, changed N/A from a year prior.
  • Inventory hit $1.0 million in Q3 2023 for Perspective Therapeutics, down from $1.1 million in the prior quarter.
  • Over the last five years, Inventory for CATX hit a ceiling of $1.6 million in Q3 2022 and a floor of $501000.0 in Q3 2019.
  • Historically, Inventory has averaged $921842.1 across 5 years, with a median of $980000.0 in 2021.
  • Biggest five-year swings in Inventory: soared 65.37% in 2021 and later tumbled 34.77% in 2023.
  • Tracing CATX's Inventory over 5 years: stood at $545000.0 in 2019, then grew by 22.02% to $665000.0 in 2020, then soared by 60.6% to $1.1 million in 2021, then surged by 31.93% to $1.4 million in 2022, then fell by 28.11% to $1.0 million in 2023.
  • Business Quant data shows Inventory for CATX at $1.0 million in Q3 2023, $1.1 million in Q2 2023, and $1.4 million in Q1 2023.